PDB Short entry for 2WOT HEADER TRANSFERASE 28-JUL-09 2WOT TITLE ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2-(2-PYRIDYL)-3-PYRIDYL)OXY)-N- TITLE 2 (3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 200-503; COMPND 5 SYNONYM: ALK5, TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I, TGF- COMPND 6 BETA RECEPTOR TYPE I, TGF-BETA TYPE I RECEPTOR, TBETAR-I, TGFR-1, COMPND 7 SERINE/THREONINE-PROTEIN KINASE RECEPTOR R4, SKR4, ACTIVIN RECEPTOR- COMPND 8 LIKE KINASE 5, ALK-5; COMPND 9 EC: 2.7.11.30; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS ALK5, KINASE, MEMBRANE, RECEPTOR, MANGANESE, SERINE/THREONINE-PROTEIN KEYWDS 2 KINASE, KINASE INHIBITOR, DISEASE MUTATION, CRANIOSYNOSTOSIS, KEYWDS 3 NUCLEOTIDE-BINDING, TGF BETA TYPE I RECEPTOR, PHOSPHOPROTEIN, KEYWDS 4 DISULFIDE BOND, AORTIC ANEURYSM, GLYCOPROTEIN, METAL-BINDING, KEYWDS 5 TRANSMEMBRANE, ATP-BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.A.NORMAN,J.E.DEBRECZENI,F.W.GOLDBERG,R.A.WARD,R.FINLAY,S.J.POWELL, AUTHOR 2 N.J.ROBERTS,A.P.DISHINGTON,H.J.GINGELL,K.F.WICKSON,A.L.ROBERTS REVDAT 6 08-MAY-19 2WOT 1 REMARK REVDAT 5 04-APR-18 2WOT 1 REMARK REVDAT 4 19-NOV-14 2WOT 1 REMARK REVDAT 3 23-NOV-11 2WOT 1 AUTHOR JRNL REVDAT 2 13-JUL-11 2WOT 1 VERSN REVDAT 1 22-SEP-09 2WOT 0 JRNL AUTH F.W.GOLDBERG,R.A.WARD,S.J.POWELL,J.E.DEBRECZENI,R.A.NORMAN, JRNL AUTH 2 N.J.ROBERTS,A.P.DISHINGTON,H.J.GINGELL,K.F.WICKSON, JRNL AUTH 3 A.L.ROBERTS JRNL TITL RAPID GENERATION OF A HIGH QUALITY LEAD FOR TRANSFORMING JRNL TITL 2 GROWTH FACTOR-BETA (TGF-BETA) TYPE I RECEPTOR (ALK5). JRNL REF J.MED.CHEM. V. 52 7901 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19736928 JRNL DOI 10.1021/JM900807W REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 23799 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1281 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1440 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.65 REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE SET COUNT : 89 REMARK 3 BIN FREE R VALUE : 0.2780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2400 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 305 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 11.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.14000 REMARK 3 B22 (A**2) : 0.12000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.156 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.142 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.095 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.013 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2489 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1669 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3371 ; 1.100 ; 1.956 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4050 ; 0.829 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 306 ; 5.692 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 112 ;35.300 ;23.393 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 429 ;12.243 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;18.509 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 364 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2774 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 512 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 500 ; 0.203 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1750 ; 0.196 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1234 ; 0.180 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1237 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 187 ; 0.133 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.130 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 45 ; 0.262 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 29 ; 0.113 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1573 ; 0.470 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 621 ; 0.085 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2422 ; 0.767 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1105 ; 1.211 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 947 ; 1.868 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 198 A 500 REMARK 3 ORIGIN FOR THE GROUP (A): 9.0266 1.4747 12.5385 REMARK 3 T TENSOR REMARK 3 T11: -0.0356 T22: -0.0202 REMARK 3 T33: -0.0297 T12: 0.0020 REMARK 3 T13: 0.0028 T23: -0.0013 REMARK 3 L TENSOR REMARK 3 L11: 0.3491 L22: 0.6322 REMARK 3 L33: 0.5347 L12: 0.0637 REMARK 3 L13: -0.0825 L23: -0.3499 REMARK 3 S TENSOR REMARK 3 S11: -0.0144 S12: -0.0243 S13: -0.0450 REMARK 3 S21: -0.0086 S22: -0.0124 S23: -0.0292 REMARK 3 S31: 0.0463 S32: 0.0005 S33: 0.0267 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2WOT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1290040587. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25080 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 22.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.530 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.94 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.980 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROP METHOD. DROPS PROTEIN REMARK 280 -PRECIPITANT 1-1, PROTEIN: 10MG/ML ALK5, PRECIPITANT: 20-30% REMARK 280 PEG8K, 100 MM PCTP BUFFER PH 8.5-9.2, 0.2 M NAAC, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.96650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.53700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.10900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.53700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.96650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.10900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 501 REMARK 465 LYS A 502 REMARK 465 MET A 503 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 223 NZ REMARK 470 ARG A 225 NE CZ NH1 NH2 REMARK 470 ARG A 240 CD NE CZ NH1 NH2 REMARK 470 LYS A 391 CG CD CE NZ REMARK 470 ARG A 442 NE CZ NH1 NH2 REMARK 470 GLN A 459 CG CD OE1 NE2 REMARK 470 LYS A 490 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 201 -94.76 -113.12 REMARK 500 ILE A 263 -60.30 -98.56 REMARK 500 ASP A 333 44.44 -151.07 REMARK 500 ASP A 351 61.47 60.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZG A 1500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PY5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITHINHIBITOR REMARK 900 RELATED ID: 1IAS RELATED DB: PDB REMARK 900 CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETARECEPTOR REMARK 900 CRYSTALLIZED WITHOUT FKBP12 REMARK 900 RELATED ID: 1B6C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA REMARK 900 RECEPTOR IN COMPLEX WITH FKBP12 REMARK 900 RELATED ID: 1VJY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA REMARK 900 TYPE I RECEPTOR REMARK 900 RELATED ID: 1RW8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATPSITE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2WOU RELATED DB: PDB REMARK 900 ALK5 IN COMPLEX WITH 4-((4-((2,6- DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL) REMARK 900 AMINO) BENZENESULFONAMIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 G198 AND G199 ARE CLONING ARTIFACTS. DBREF 2WOT A 198 199 PDB 2WOT 2WOT 198 199 DBREF 2WOT A 200 503 UNP P36897 TGFR1_HUMAN 200 503 SEQRES 1 A 306 GLY GLY THR ILE ALA ARG THR ILE VAL LEU GLN GLU SER SEQRES 2 A 306 ILE GLY LYS GLY ARG PHE GLY GLU VAL TRP ARG GLY LYS SEQRES 3 A 306 TRP ARG GLY GLU GLU VAL ALA VAL LYS ILE PHE SER SER SEQRES 4 A 306 ARG GLU GLU ARG SER TRP PHE ARG GLU ALA GLU ILE TYR SEQRES 5 A 306 GLN THR VAL MET LEU ARG HIS GLU ASN ILE LEU GLY PHE SEQRES 6 A 306 ILE ALA ALA ASP ASN LYS ASP ASN GLY THR TRP THR GLN SEQRES 7 A 306 LEU TRP LEU VAL SER ASP TYR HIS GLU HIS GLY SER LEU SEQRES 8 A 306 PHE ASP TYR LEU ASN ARG TYR THR VAL THR VAL GLU GLY SEQRES 9 A 306 MET ILE LYS LEU ALA LEU SER THR ALA SER GLY LEU ALA SEQRES 10 A 306 HIS LEU HIS MET GLU ILE VAL GLY THR GLN GLY LYS PRO SEQRES 11 A 306 ALA ILE ALA HIS ARG ASP LEU LYS SER LYS ASN ILE LEU SEQRES 12 A 306 VAL LYS LYS ASN GLY THR CYS CYS ILE ALA ASP LEU GLY SEQRES 13 A 306 LEU ALA VAL ARG HIS ASP SER ALA THR ASP THR ILE ASP SEQRES 14 A 306 ILE ALA PRO ASN HIS ARG VAL GLY THR LYS ARG TYR MET SEQRES 15 A 306 ALA PRO GLU VAL LEU ASP ASP SER ILE ASN MET LYS HIS SEQRES 16 A 306 PHE GLU SER PHE LYS ARG ALA ASP ILE TYR ALA MET GLY SEQRES 17 A 306 LEU VAL PHE TRP GLU ILE ALA ARG ARG CYS SER ILE GLY SEQRES 18 A 306 GLY ILE HIS GLU ASP TYR GLN LEU PRO TYR TYR ASP LEU SEQRES 19 A 306 VAL PRO SER ASP PRO SER VAL GLU GLU MET ARG LYS VAL SEQRES 20 A 306 VAL CYS GLU GLN LYS LEU ARG PRO ASN ILE PRO ASN ARG SEQRES 21 A 306 TRP GLN SER CYS GLU ALA LEU ARG VAL MET ALA LYS ILE SEQRES 22 A 306 MET ARG GLU CYS TRP TYR ALA ASN GLY ALA ALA ARG LEU SEQRES 23 A 306 THR ALA LEU ARG ILE LYS LYS THR LEU SER GLN LEU SER SEQRES 24 A 306 GLN GLN GLU GLY ILE LYS MET HET ZZG A1500 34 HET EDO A1501 4 HETNAM ZZG 4-[(5,6-DIMETHYL-2,2'-BIPYRIDIN-3-YL)OXY]-N-(3,4,5- HETNAM 2 ZZG TRIMETHOXYPHENYL)PYRIDIN-2-AMINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ZZG C26 H26 N4 O4 FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *305(H2 O) HELIX 1 1 ILE A 201 ARG A 203 5 3 HELIX 2 2 SER A 235 ARG A 237 5 3 HELIX 3 3 GLU A 238 GLN A 250 1 13 HELIX 4 4 SER A 287 TYR A 295 1 9 HELIX 5 5 MET A 302 SER A 311 1 10 HELIX 6 6 LEU A 313 MET A 318 1 6 HELIX 7 7 LYS A 335 LYS A 337 5 3 HELIX 8 8 THR A 375 MET A 379 5 5 HELIX 9 9 ALA A 380 ASP A 385 1 6 HELIX 10 10 HIS A 392 MET A 404 1 13 HELIX 11 11 LEU A 406 ARG A 414 1 9 HELIX 12 12 SER A 437 CYS A 446 1 10 HELIX 13 13 PRO A 455 GLN A 459 5 5 HELIX 14 14 CYS A 461 TRP A 475 1 15 HELIX 15 15 THR A 484 GLU A 499 1 16 SHEET 1 AA 5 ILE A 205 SER A 210 0 SHEET 2 AA 5 VAL A 219 TRP A 224 -1 O ARG A 221 N GLN A 208 SHEET 3 AA 5 ALA A 230 PHE A 234 -1 O VAL A 231 N TRP A 220 SHEET 4 AA 5 THR A 274 SER A 280 -1 O LEU A 276 N PHE A 234 SHEET 5 AA 5 ALA A 264 ASP A 269 -1 O ALA A 264 N VAL A 279 SHEET 1 AB 3 ALA A 328 ALA A 330 0 SHEET 2 AB 3 VAL A 356 ASP A 359 -1 O VAL A 356 N ALA A 330 SHEET 3 AB 3 THR A 364 ILE A 365 -1 O THR A 364 N ASP A 359 SHEET 1 AC 2 ILE A 339 VAL A 341 0 SHEET 2 AC 2 CYS A 347 ILE A 349 -1 O CYS A 348 N LEU A 340 SITE 1 AC1 3 TRP A 273 GLN A 275 GLN A 448 SITE 1 AC2 17 ILE A 211 VAL A 219 ALA A 230 LYS A 232 SITE 2 AC2 17 LEU A 278 SER A 280 ASP A 281 TYR A 282 SITE 3 AC2 17 HIS A 283 GLU A 284 GLY A 286 ASP A 290 SITE 4 AC2 17 THR A 323 ASN A 338 LEU A 340 ASP A 351 SITE 5 AC2 17 HOH A2051 CRYST1 41.933 78.218 89.074 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023848 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012785 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011227 0.00000